U.K. Pharmaceuticals & Biotech High Insider Buying

GSK

Market Cap: UK£78.7b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.1b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Oxford Nanopore Technologies

Market Cap: UK£1.1b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.

Animalcare Group

Market Cap: UK£228.9m

Develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally.

Bioventix

Market Cap: UK£90.1m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Faron Pharmaceuticals Oy

Market Cap: UK£86.2m

Operates as a clinical stage drug discovery and development company.

OptiBiotix Health

Market Cap: UK£6.1m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.